- Home
- Publications
- Publication Search
- Publication Details
Title
Application of Anti-Inflammatory Agents in Prostate Cancer
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 8, Pages 2680
Publisher
MDPI AG
Online
2020-08-20
DOI
10.3390/jcm9082680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Niclosamide suppresses macrophage-induced inflammation in endometriosis†
- (2020) Nikola Sekulovski et al. BIOLOGY OF REPRODUCTION
- Influence of Diet and Nutrition on Prostate Cancer
- (2020) Makoto Matsushita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- CD4 + T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion
- (2020) Sen Liu et al. PROSTATE
- IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages
- (2020) Ik-Hwan Han et al. PLoS Neglected Tropical Diseases
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis
- (2019) Charlotte Skriver et al. ANNALS OF INTERNAL MEDICINE
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Obesity, Inflammation, and Prostate Cancer
- (2019) Kazutoshi Fujita et al. Journal of Clinical Medicine
- Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression
- (2019) Shintaro Narita et al. Journal of Clinical Medicine
- Role of myeloid-derived suppressor cells in immune checkpoint inhibitor therapy in cancer
- (2019) Su-Myeong Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
- (2019) William D Tap et al. LANCET
- The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
- (2019) Rebecka Hellsten et al. PROSTATE
- Prostate Cancer
- (2019) Aradhana Rani et al. AMERICAN JOURNAL OF PATHOLOGY
- Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
- (2019) Tommaso Cai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis
- (2019) Masahito Watanabe et al. PROSTATE
- Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages
- (2019) Pei Liang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
- (2019) Diletta Di Mitri et al. Cell Reports
- The Microbiome and Prostate Cancer Risk
- (2019) Karen M. Wheeler et al. Current Urology Reports
- Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
- (2019) Takuji Hayashi et al. Cancers
- Past, Current, and Future of Immunotherapies for Prostate Cancer
- (2019) Adeline N. Boettcher et al. Frontiers in Oncology
- Crosstalk between myeloid‐derived suppressor cells and the immune system in prostate cancer
- (2019) Mohammad‐Javad Sanaei et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Heterogeneity of human prostate carcinoma‐associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment
- (2019) Renee E. Vickman et al. PROSTATE
- Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer
- (2019) Roberto Benelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer
- (2018) Zeyad D. Nassar et al. BJU INTERNATIONAL
- Targeting myeloid-derived suppressor cells for cancer immunotherapy
- (2018) Yijun Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
- (2018) Teizo Yoshimura Cellular & Molecular Immunology
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling
- (2018) Takuji Hayashi et al. CLINICAL CANCER RESEARCH
- Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
- (2018) Qiuli Liu et al. CLINICAL CANCER RESEARCH
- Myeloid derived-suppressor cells: their role in cancer and obesity
- (2018) Suzanne Ostrand-Rosenberg CURRENT OPINION IN IMMUNOLOGY
- Macrophage targeting: opening new possibilities for cancer immunotherapy
- (2018) Luca Cassetta et al. IMMUNOLOGY
- Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells
- (2018) Cho-Rong Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
- (2018) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis
- (2018) Shaleen R. Vasavada et al. JOURNAL OF UROLOGY
- Complex roles of the old drug aspirin in cancer chemoprevention and therapy
- (2018) Hui Hua et al. MEDICINAL RESEARCH REVIEWS
- An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
- (2018) Ming Chen et al. NATURE GENETICS
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- The Associations between Dietary Inflammatory Index and the Incidence of Breast and Prostate Cancer: A Systematic Review and Meta-Analysis
- (2018) Sajjad Moradi et al. NUTRITION
- COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
- (2018) Rachana Garg et al. ONCOGENE
- The microbiome in prostate inflammation and prostate cancer
- (2018) Corey M. Porter et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies
- (2018) Monireh Mohsenzadegan et al. Recent Patents on Anti-Cancer Drug Discovery
- Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
- (2018) Jonathan F. Anker et al. Nature Communications
- Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer
- (2018) Elena Jachetti et al. Cancer Immunology Research
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer
- (2018) Wei Guan et al. ENDOCRINE-RELATED CANCER
- Role of systemic inflammatory response markers in urological malignancy
- (2018) Yoshio Ohno INTERNATIONAL JOURNAL OF UROLOGY
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
- (2018) Shan Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
- (2018) Eric Fox et al. Frontiers in Oncology
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
- (2018) Dayson Moreira et al. CLINICAL CANCER RESEARCH
- Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten -deficient model mice
- (2018) Takuji Hayashi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Cyclooxygenase-2 in cancer: A review
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- The obese adipose tissue microenvironment in cancer development and progression
- (2018) Daniela F. Quail et al. Nature Reviews Endocrinology
- M2 macrophages and regulatory T cells in lethal prostate cancer
- (2018) Ann Erlandsson et al. PROSTATE
- Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
- (2018) Franziska Eckert et al. Frontiers in Immunology
- Advances in antitumor effects of NSAIDs
- (2018) Zhen Zhang et al. Cancer Management and Research
- Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study
- (2017) Mary K. Downer et al. EUROPEAN UROLOGY
- Tumor-associated macrophages: implications in cancer immunotherapy
- (2017) Amy J Petty et al. Immunotherapy
- Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes
- (2017) Mackenzie E. Fowler et al. INTERNATIONAL JOURNAL OF CANCER
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
- (2017) Hernan Roca et al. JOURNAL OF CLINICAL INVESTIGATION
- Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer
- (2017) Signe Benzon Larsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
- (2017) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
- (2017) Zoila Lopez-Bujanda et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase
- (2017) Irina Lerman et al. MOLECULAR CANCER RESEARCH
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- The inflammatory microenvironment and microbiome in prostate cancer development
- (2017) Karen S. Sfanos et al. Nature Reviews Urology
- Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model
- (2017) Qiuyang Zhang et al. PROSTATE
- Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimens
- (2017) Takuji Hayashi et al. PROSTATE
- Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis
- (2017) Jian Cao et al. Oncotarget
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Metformin and Prostate Cancer: a New Role for an Old Drug
- (2017) Jessica Whitburn et al. Current Urology Reports
- Adipocytes and Macrophages Interplay in the Orchestration of Tumor Microenvironment: New Implications in Cancer Progression
- (2017) Luís Henrique Corrêa et al. Frontiers in Immunology
- Biomonitoring DNA Adducts of Cooked Meat Carcinogens in Human Prostate by Nano Liquid Chromatography–High Resolution Tandem Mass Spectrometry: Identification of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine DNA Adduct
- (2016) Shun Xiao et al. ANALYTICAL CHEMISTRY
- Regulation of prostate cancer progression by the tumor microenvironment
- (2016) Stephen L. Shiao et al. CANCER LETTERS
- Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1
- (2016) Lenard M. Lichtenberger et al. Cancer Prevention Research
- ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
- (2016) Christopher Coyle et al. Contemporary Clinical Trials
- Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up
- (2016) Jennifer R. Rider et al. EUROPEAN UROLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
- (2016) Cora Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
- (2016) Alessandro Sciarra et al. Journal of Inflammation-London
- The current evidence on statin use and prostate cancer prevention: are we there yet?
- (2016) Mahmoud A. Alfaqih et al. Nature Reviews Urology
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
- (2016) Y Deng et al. ONCOGENE
- The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels
- (2016) Viranda H. Jayalath et al. PROSTATE
- Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells
- (2016) Ravikumar Muthuswamy et al. PROSTATE
- Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression
- (2016) Pei Liang et al. PROSTATE
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Statin use and mortality of patients with prostate cancer: a meta-analysis
- (2016) Jia Wang et al. OncoTargets and Therapy
- Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
- (2016) Victor Laurent et al. Nature Communications
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
- (2016) Takuji Hayashi et al. Oncotarget
- Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
- (2016) Aerken Maolake et al. Oncotarget
- Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
- (2016) Rosa Divella et al. Journal of Cancer
- Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
- (2016) Yin Cao et al. JAMA Oncology
- Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
- (2016) Xiaobin Gu et al. Scientific Reports
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals
- (2015) S. Rohrmann et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites
- (2015) K. S. Sfanos et al. Cancer Prevention Research
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
- (2015) J. Escamilla et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- (2015) D. M. S. Hossain et al. CLINICAL CANCER RESEARCH
- Genomic rearrangements in prostate cancer
- (2015) Christopher E. Barbieri et al. CURRENT OPINION IN UROLOGY
- Inflammation and prostate cancer: friends or foe?
- (2015) Gianluigi Taverna et al. INFLAMMATION RESEARCH
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression
- (2015) Brian W Simons et al. JOURNAL OF PATHOLOGY
- CREB pathway links PGE2 signaling with macrophage polarization
- (2015) Bing Luan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
- (2015) Giovanni Luca Gravina et al. PROSTATE
- Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity
- (2015) Yusuke Ito et al. PROSTATE
- Intraprostatic inflammation is positively associated with serum PSA in men with PSA
- (2015) M H Umbehr et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma
- (2015) WENXUE HU et al. Oncology Letters
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
- (2015) Qi Chen et al. Drug Design Development and Therapy
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Phenotype, development, and biological function of myeloid-derived suppressor cells
- (2015) Yang Zhao et al. OncoImmunology
- Immune Infiltration and Prostate Cancer
- (2015) Amy Strasner et al. Frontiers in Oncology
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
- (2014) T Veitonmäki et al. BRITISH JOURNAL OF CANCER
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
- (2014) B. Gurel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
- (2014) Manja Idorn et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Pathways: Myeloid Complicity in Cancer
- (2014) I. M. Stromnes et al. CLINICAL CANCER RESEARCH
- Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
- (2014) A. C. Vidal et al. CLINICAL CANCER RESEARCH
- Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2014) C. Liu et al. CLINICAL CANCER RESEARCH
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Daily Aspirin Use and Prostate Cancer–Specific Mortality in a Large Cohort of Men with Nonmetastatic Prostate Cancer
- (2014) Eric J. Jacobs et al. JOURNAL OF CLINICAL ONCOLOGY
- Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
- (2014) Daniel W. Beury et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
- (2014) A. J. Garcia et al. MOLECULAR AND CELLULAR BIOLOGY
- Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
- (2014) Diletta Di Mitri et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- The Role of Prostatitis in Prostate Cancer: Meta-Analysis
- (2014) Junyi Jiang et al. PLoS One
- COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins
- (2014) Jared Bieniek et al. PROSTATE
- EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer
- (2014) E Kashiwagi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Statin Medications Are Associated With a Lower Probability of Having an Abnormal Screening Prostate-specific Antigen Result
- (2014) Ying Shi et al. UROLOGY
- Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
- (2014) Roberto Pili et al. OncoTargets and Therapy
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
- (2014) M. Lanciotti et al. Biomed Research International
- Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
- (2014) L. Shen et al. Cancer Immunology Research
- Androgen deprivation therapy: evidence-based management of side effects
- (2013) Hamed Ahmadi et al. BJU INTERNATIONAL
- Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial
- (2013) Tytti H. Yli-Hemminki et al. BJU INTERNATIONAL
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study
- (2013) Daniel M. Moreira et al. CANCER
- Mechanisms of action of tasquinimod on the tumour microenvironment
- (2013) E. Raymond et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Obesity Promotes Breast Cancer by CCL2-Mediated Macrophage Recruitment and Angiogenesis
- (2013) L. M. Arendt et al. CANCER RESEARCH
- Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
- (2013) L.-Y. Fang et al. CANCER RESEARCH
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
- (2013) J. Xu et al. CANCER RESEARCH
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Inflammation and prostate carcinogenesis
- (2013) Yasutomo Nakai et al. INTERNATIONAL JOURNAL OF UROLOGY
- Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
- (2013) Davide Brusa et al. INTERNATIONAL JOURNAL OF UROLOGY
- Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc
- (2013) K. Hatano et al. MOLECULAR CANCER RESEARCH
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Future directions in the prevention of prostate cancer
- (2013) Ian M. Thompson et al. Nature Reviews Clinical Oncology
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- Immunohistochemical Analysis of Inflammatory Cells in Benign and Precancerous Lesions and Carcinoma of the Prostate
- (2013) Tomomi Fujii et al. PATHOBIOLOGY
- Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model
- (2013) Yi-Rang Na et al. PLoS One
- Designing and developing a literature-derived, population-based dietary inflammatory index
- (2013) Nitin Shivappa et al. PUBLIC HEALTH NUTRITION
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
- (2012) F M Shebl et al. BRITISH JOURNAL OF CANCER
- Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1
- (2012) Yanfei Peng et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients
- (2012) A. VRAL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
- (2012) Kevin S. Choe et al. JOURNAL OF CLINICAL ONCOLOGY
- Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
- (2012) Chun-Te Wu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
- (2012) Nicholas D James et al. LANCET ONCOLOGY
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
- (2012) Dipika Bansal et al. PLoS One
- A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling
- (2012) Mingguo Huang et al. PROSTATE
- Low serum neutrophil count predicts a positive prostate biopsy
- (2012) K Fujita et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- Differential macrophage programming in the tumor microenvironment
- (2012) Brian Ruffell et al. TRENDS IN IMMUNOLOGY
- Metformin in prostate cancer: two for the price of one
- (2011) A. Clements et al. ANNALS OF ONCOLOGY
- A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy
- (2011) Jenny P. Nobes et al. BJU INTERNATIONAL
- Inflammation, Focal Atrophic Lesions, and Prostatic Intraepithelial Neoplasia with Respect to Risk of Lethal Prostate Cancer
- (2011) S. Davidsson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
- (2011) J. Godin-Ethier et al. CLINICAL CANCER RESEARCH
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Prostate cancer and inflammation: the evidence
- (2011) Karen S Sfanos et al. HISTOPATHOLOGY
- Gr-1+CD11b+Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity
- (2011) Sheng Xia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prostatic Inflammation Detected in Initial Biopsy Specimens and Urinary Pyuria are Predictors of Negative Repeat Prostate Biopsy
- (2011) Kazutoshi Fujita et al. JOURNAL OF UROLOGY
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
- (2011) Patricia McGettigan et al. PLOS MEDICINE
- Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
- (2010) Norio Nonomura et al. BJU INTERNATIONAL
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status
- (2010) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006
- (2010) Preet K. Dhillon et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination Survey
- (2010) Steven L. Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo
- (2010) Parisa Abedinpour et al. PROSTATE
- Oxidative stress in prostate cancer
- (2009) Lakshmipathi Khandrika et al. CANCER LETTERS
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
- (2009) Aditya Bardia et al. CURRENT OPINION IN PHARMACOLOGY
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
- (2009) Jian Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
- (2009) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
- (2009) Philippe O. Gannon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4
- (2009) Stephanie K. Bunt et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
- (2008) S. Jain et al. CANCER RESEARCH
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials
- (2008) Scott D. Solomon et al. CIRCULATION
- Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing
- (2008) K. S. Sfanos et al. CLINICAL CANCER RESEARCH
- The Influence of Statin Medications on Prostate-specific Antigen Levels
- (2008) Robert J. Hamilton et al. JNCI-Journal of the National Cancer Institute
- Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation
- (2008) Kazutoshi Fujita et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search